Dr. Hanno Steen is an Associate Professor of Pathology at Harvard Medical School and Director of Proteomics at Boston Children’s Hospital, where he is also member of the Department of Pathology, Division of Infectious Diseases, the Precision Vaccines Program and the Neurobiology Program. Dr. Steen studied in chemistry in at Freiburg University in Freiburg/Germany, at UMIST in Manchester/UK and at the Swiss Federal Institute of Technology (ETH) in Zurich/Switzerland before joining Matthias Mann’s group at (then) the University of Southern Denmark in Odense/Denmark. There he completed his PhD in the field of mass spectrometry-based proteomics with a special focus on the detection and quantification of post-translational modifications. Upon obtaining his PhD in 2002, he moved to Harvard Medical School to complete postdoctoral fellowships in the laboratories of Drs. Steve Gygi and Mark Kirschner. In 2015, he joined the Department of Pathology at Boston Children’s Hospital to establish his own lab. The work in his lab is currently focused on i) new and better methods for turning proteomics data into clinically relevant information, ii) the development pipelines for high throughput proteomics in order to enable translational and clinical proteomics studies, and iii) to identify biomarkers and potential therapeutic targets in the context of neurodegeneration and vaccinology. Dr. Steen’s work has led to more than 150 publications and several patents around urinary biomarkers.